Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Cell Tissue Bank ; 23(4): 791-805, 2022 Dec.
Article in English | MEDLINE | ID: mdl-35037183

ABSTRACT

Glutaraldehyde (GA)-fixed bovine pericardial patches remain the cardiovascular industry standard despite reports of degradation, thickening, inflammation, calcification and lack of tissue remodelling. Decellularization provides the opportunity to attenuate some of these immune-mediated processes. This study compared the mechanical and morphological integrity of bovine pericardium that is GA-fixated (Glycar® patches) or decellularized (BPS), using a proprietary protocol, following implantation in an ovine model. The impact of the processing methods on tissue strength and morphology was assessed prior to implantation. Pericardial patches were then implanted in the descending aorta and main pulmonary artery of juvenile sheep (n = 6 per group) for 180 days, and clinically evaluated using echocardiography. At explanation, patches were evaluated for strength, calcification and biological interaction. Histology demonstrated a wave-like appearance of well-separated collagen fibers for BPS scaffolds that provided pore sizes adequate to promote fibroblast infiltration. The collagen of the Glycar® patches showed loss of collagen fiber integrity, making the collagen densely compacted, contributing to insignificant recipient cell infiltration. The clinical performance of both groups was excellent, and echocardiography confirmed the absence of aneurysm formation, calcification and degeneration. Explanted Glycar® patches demonstrated cells in abundance within the fibrous encapsulation that separated the implant from the host tissue. More importantly, the fibrous encapsulation also contributed to patch thickening of both the explanted aorta and pulmonary patches. The decellularized pericardial scaffolds demonstrated recellularization, resistance to calcification, re-endothelialization and adequate strength after 180-day implantation. The proprietary decellularization protocol produced pericardial scaffolds that could be considered as an alternative to GA-fixed pericardial patches.


Subject(s)
Bioprosthesis , Calcinosis , Animals , Sheep , Cattle , Glutaral , Pericardium , Calcinosis/pathology , Collagen
2.
Biomed Phys Eng Express ; 6(6)2020 09 29.
Article in English | MEDLINE | ID: mdl-35066494

ABSTRACT

Decellularization is a promising method for obtaining extracellular matrix scaffolds (ECM) to be used as replacement material in reconstructive procedures. The effectiveness of decellularization and the alterations to the ECM vary, depending on several factors, including the tissue source, composition and density. With an optimized decellularization process, decellularized scaffolds can preserve the spatial and temporal ECM microenvironment, which play an integral role in modulating cell migration, proliferation and differentiation. The exploration of a variety of decellularization protocols has led to mixed outcomes and comparisons between decellularization protocols could not attribute these differences to any single step in a multiple-step process. This study aimed to characterize the effects of each step of a multifactorial decellularization method on the scaffold structure and mechanical integrity of bovine pericardium. Each step of the decellularization process and the effect on the tissue was assessed using hematoxylin and eosin staining, electron microscopy, total protein, ECM protein and triglyceride quantification. The biomechanical properties were assessed using uniaxial tensile strength testing. Cell lysis occurred mainly during the detergent and alcohol steps. Collagen structural damage occurred during the detergent and alcohol steps, with no significant decreased in collagen concentration. No significant damage to elastin could be shown throughout the process, however glycosaminoglycans were significantly removed by detergent treatment. Triglycerides were removed mostly by the alcohol treatment. The strength of the pericardium decreased somewhat after each step of the protocol. It is important to characterize each decellularization protocol with regards to the decellularization efficiency and the effect on the ECM proteins structure and function to accurately evaluatein vivooutcomes.


Subject(s)
Detergents , Tissue Scaffolds , Animals , Cattle , Collagen/metabolism , Detergents/analysis , Detergents/metabolism , Detergents/pharmacology , Extracellular Matrix , Pericardium , Tissue Scaffolds/chemistry
3.
J Hosp Infect ; 94(3): 295-304, 2016 Nov.
Article in English | MEDLINE | ID: mdl-27424948

ABSTRACT

Surgical site infections (SSIs) are among the most common healthcare-associated infections, and contribute significantly to patient morbidity and healthcare costs. Staphylococcus aureus is the most common microbial cause. The epidemiology of S. aureus is changing with the dissemination of newer clones and the emergence of mupirocin resistance. The prevention and control of SSIs is multi-modal, and this article reviews the evidence on the value of screening for nasal carriage of S. aureus and subsequent decolonization of positive patients pre-operatively. Pre-operative screening, using culture- or molecular-based methods, and subsequent decolonization of patients who are positive for meticillin-susceptible S. aureus and meticillin-resistant S. aureus (MRSA) reduces SSIs and hospital stay. This applies especially to major clean surgery, such as cardiothoracic and orthopaedic, involving the insertion of implanted devices. However, it requires a multi-disciplinary approach coupled with patient education. Universal decolonization pre-operatively without screening for S. aureus may compromise the capacity to monitor for the emergence of new clones of S. aureus, contribute to mupirocin resistance, and prevent the adjustment of surgical prophylaxis for MRSA (i.e. replacement of a beta-lactam agent with a glycopeptide or alternative).


Subject(s)
Anti-Bacterial Agents/therapeutic use , Carrier State/diagnosis , Mass Screening/methods , Staphylococcal Infections/diagnosis , Staphylococcus aureus/isolation & purification , Surgical Wound Infection/prevention & control , Carrier State/drug therapy , Humans , Staphylococcal Infections/drug therapy , Surgical Wound Infection/epidemiology , Surgical Wound Infection/microbiology
6.
Article in English | MEDLINE | ID: mdl-23439388

ABSTRACT

Since the first heterotopic implantation of a biological heart valve in 1955 by Murray, bioprostheses have been steadily improved. For allografts different methods have been evaluated and modified to stabilize and preserve the available tissue. Xenografts were fixed to cross-link the connective tissue as well as prevent immunogenic reactions. Nevertheless, gluteraldehyde fixation leads to structural deterioration, which could only be partially reduced by different kinds of anti-mineralization treatment. Due to preservation and fixation, allografts and xenografts become non-viable bioprostheses with a lack of remodelling, regeneration and growth. Tissue engineering is a possible key to overcome these disadvantages as it will provide living tissue with remodelling, regeneration and growth potential. This overview will look at the key points to provide such tissue engineered heart valves by creating an appropriate scaffold where cells can grow, either in vitro or in vivo and remodel a neo-scaffold which will lead to a functional autologous heart valve, and show initial clinical results.

7.
Article in English | MEDLINE | ID: mdl-23440902

ABSTRACT

Several prostheses are available to replace degenerative diseased aortic valves with unique advantages and disadvantages. Bioprotheses show excellent hemodynamic behavior and low risk of thromboembolic complications, but are limited by tissue deterioration. Mechanical heart valves have extended durability, but permanent anticoagulation is mandatory. Tissue engineering created a new generation heart valve, which overcome limitations of biological and mechanical heart valves due to remodelling, regeneration and growth potential. Several publications are available in using tissue engineered heart valves in right ventricular outflow tract reconstruction. Limited experiences are available on these heart valves implanted into the systemic circulation. This overview shows the current state on the development of tissue engineered aortic heart valves.

8.
J Hosp Infect ; 72(2): 119-26, 2009 Jun.
Article in English | MEDLINE | ID: mdl-19285360

ABSTRACT

Surgical site infection (SSI) is a serious complication after cardiac surgery. This case-control study investigated the effect of a cyanoacrylate-based microbial skin sealant (InteguSeal) applied preoperatively on the SSI rate in patients undergoing coronary artery bypass graft (CABG) surgery. Of 676 patients who underwent CABG surgery with or without concomitant procedure(s) between March and November 2007, 545 received standard preoperative care and 131 also received pretreatment with the microbial sealant. Of these, 90 cases pretreated with microbial sealant and 90 controls were matched using established preoperative and intraoperative risk factors for SSI. Preoperative risk scores for SSI were 9.9+/-4.3 and 9.7+/-4.0 (P=0.747) for the microbial sealant and the control group, respectively, and combined preoperative-intraoperative risk scores were 9.7+/-4.1 and 8.7+/-3.5 (P=0.080), respectively. Carotid artery disease (P=0.019), congestive heart failure (P=0.019), acute myocardial infarction (P=0.001) and emergency surgery (P=0.026) were significantly more common in the microbial sealant group. Follow-up was 100% for both groups. Superficial or deep sternal infection 30 days post surgery developed in seven patients (7.8%) in the control group compared with one patient (1.1%) in the microbial sealant group (odds ratio 7.5). In summary, the inclusion of microbial sealant in preoperative patient preparation seems to reduce the incidence of SSI following CABG surgery; further larger studies are needed before firm conclusions can be drawn.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Coronary Artery Bypass/adverse effects , Cross Infection/prevention & control , Fibrin Tissue Adhesive/therapeutic use , Surgical Wound Infection/prevention & control , Aged , Case-Control Studies , Cross Infection/epidemiology , Female , Humans , Male , Middle Aged , Prevalence , Surgical Wound Infection/epidemiology
9.
J Hosp Infect ; 70 Suppl 2: 15-20, 2008 Nov.
Article in English | MEDLINE | ID: mdl-19022117

ABSTRACT

Surgical site infections (SSIs) remain an important cause of postoperative morbidity and mortality and generate considerable additional healthcare and societal costs. Most SSIs are caused by skin-derived bacteria such as Staphylococcus aureus and coagulase-negative staphylococci. Antimicrobial resistance among these and other clinically important pathogens is an increasing problem. Thus, while the overall risk of SSI is influenced by numerous patient- and procedure-specific characteristics, effective antibiotic prophylaxis and skin preparation are important components of the polymodal approach to SSI prevention. Published guidelines recommend that selection of antimicrobial agents for prophylactic use should take into account the expected flora, the ability of the agent to reach the target tissue at appropriate concentrations, bacterial resistance patterns and drug pharmacokinetics. Consistent with proper antimicrobial stewardship, antibiotic prophylaxis should use an appropriate drug and optimise the dose and duration of treatment to minimise toxicity and conditions for selection of resistant bacterial strains. Because the risk of developing SSI depends in part on the extent of wound contamination with virulent bacteria, efficient preoperative patient skin preparation is essential to decrease the number of potential wound contaminants. A recent development to reduce the risk of surgical site contamination by skin flora is a cyanoacrylate-based microbial sealant that is applied before surgery and dries to immobilise skin bacteria under a breathable film. This novel mechanism of action is not compromised by, and does not promote, bacterial resistance and, with minimal potential to cause skin reactions, the microbial sealant is an innovative addition to available options for SSI prophylaxis.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antibiotic Prophylaxis , Cyanoacrylates/therapeutic use , Drug Resistance, Bacterial , Skin/microbiology , Surgical Wound Infection/prevention & control , Aged , Anti-Bacterial Agents/pharmacology , Gram-Negative Bacteria/drug effects , Gram-Negative Bacterial Infections/microbiology , Gram-Negative Bacterial Infections/prevention & control , Gram-Positive Bacterial Infections/microbiology , Gram-Positive Bacterial Infections/prevention & control , Gram-Positive Cocci/drug effects , Humans , Preoperative Care , Skin/drug effects , Surgical Wound Infection/microbiology
10.
J Int Med Res ; 35(1): 72-83, 2007.
Article in English | MEDLINE | ID: mdl-17408057

ABSTRACT

We studied the influence of sequential involvement of the gastrointestinal (GI) tract on the development of multiple organ dysfunction (MOD) after cardiopulmonary bypass (CPB). One hundred and forty-six patients undergoing elective cardiac surgery were included in this prospective observational study. Standardized oral inert-sugar tests (sucrose, lactulose, mannitol, sucralose) were performed before and after CPB in different patients. Enzyme-linked immunosorbent assay of plasma levels of endotoxin core antibodies (EndoCAb) were performed peri-operatively. The functional mucosal surface was calculated from the amount of mannitol absorbed from the GI tract. Lower urine concentrations of absorbed mannitol were observed pre-operatively in patients developing MOD. In binary logistic regression this was an independent parameter. Decreased plasma concentrations of EndoCAb after surgery were seen in every patient, but were more significant in patients developing MOD. A reduced pre-operative functional mucosal surface may predict the early occurrence of MOD after surgery.


Subject(s)
Cardiopulmonary Bypass , Gastrointestinal Tract/physiology , Multiple Organ Failure/physiopathology , Aged , Female , Humans , Male
11.
J Heart Valve Dis ; 15(4): 545-8, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16901052

ABSTRACT

BACKGROUND AND AIM OF THE STUDY: The 3F equine aortic bioprosthesis is a new stentless valve which is currently undergoing evaluation in a multicenter clinical trial and is considered to have superior hemodynamic performance. Herein is reported the authors' initial experience with the 3F valve, focusing on the hemodynamic performance of the device. METHODS: Between March 2002 and October 2003, 35 patients (age range 61-86 years) underwent aortic valve replacement with the 3F valve implanted in the subcoronary position. Evaluation of valve hemodynamic performance was assessed at discharge (postoperative day 5 +/- 2), at 3-6 months, and at 11-14 months' follow up by means of transthoracic echocardiography. The mean preoperative transvalvular pressure gradient was 63 +/- 14 mmHg. Before surgery, all patients were in NYHA class III or IV, despite aggressive medical treatment. Five patients underwent concomitant coronary artery bypass grafting. RESULTS: The implanted valve sizes ranged from 21 to 29 mm. There were no operative deaths and no major perioperative complications. After 12 months, mean pressure gradients for the 23-, 25-, 27- and 29-mm valves were 13, 13, 12 and 9 mmHg, respectively. Mean systolic pressure gradients and NYHA class were improved significantly after surgery. Mild signs of hemolysis and minimal central regurgitation were detected in some patients, but were of no clinical importance. Valve dysfunction or mechanical failure did not occur during the follow up period. CONCLUSION: Because of its flexible structure, the 3F aortic bioprosthesis is simple to implant, and no major adverse effects have been associated with such valve implantation at the authors' center. Transprosthetic gradients appeared to regress at 6-12 months' follow up. The durability of the device is yet to be established in ongoing long-term trials.


Subject(s)
Aortic Valve , Bioprosthesis , Heart Valve Prosthesis , Aged , Aged, 80 and over , Animals , Echocardiography , Evaluation Studies as Topic , Follow-Up Studies , Heart Valve Prosthesis Implantation , Hemodynamics , Horses , Humans , Middle Aged , Prospective Studies , Prosthesis Design , Time Factors
12.
Eur Surg Res ; 38(1): 54-61, 2006.
Article in English | MEDLINE | ID: mdl-16490995

ABSTRACT

OBJECTIVE: A challenging issue is to create a heart valve with growth and remodeling potential, which would be of great interest for congenital heart valve surgery. This study was performed to evaluate the growth and remodeling potentials of a decellularized heart valve. METHODS: In 4 juvenile sheep (age 12 +/- 1 weeks) with a weight of 24.3 +/- 4.4 kg, a 17-mm diameter decellularized porcine valve was implanted as pulmonary valve replacement. Valve growth was evaluated by transthoracic echocardiography. At explantation, valves were evaluated by gross examination, light microscopy (hematoxylin and eosin, von Kossa, Sirius red, Weigert and Gomori staining), electron microscopy and immunohistochemistry. Atomic absorption spectrometry was performed to evaluate calcium content. RESULTS: All animals showed fast recovery. The mean follow-up was 9.0 +/- 1.8 months. All sheep at least doubled their weight (54.3 +/- 9.2 kg). Echocardiography showed no regurgitation and a flow velocity of 0.7 +/- 0.1 m/s at the latest follow-up. The valve diameter increased from 17.6 +/- 0.5 to 27.5 +/- 2.1 mm (p < 0.018). Gross examination showed a similar wall thickness of the implanted valve and native pulmonary wall, with smooth and pliable leaflets. Histology showed a monolayer of endothelial cells, fibroblast ingrowth and production of new collagen. No calcification was seen at von Kossa staining, confirmed by low calcium content levels of the valve wall and leaflets at atomic absorption spectrometry. CONCLUSIONS: This glutaraldehyde-free heart valve showed not only the absence of calcification, but also remodeling and growth potential.


Subject(s)
Glutaral/pharmacology , Heart Valve Prosthesis , Heart Valves/growth & development , Pulmonary Valve/growth & development , Pulmonary Valve/transplantation , Animals , Echocardiography, Transesophageal , Heart Valves/drug effects , Models, Animal , Sheep , Swine , Transplantation, Heterologous
14.
Thorac Cardiovasc Surg ; 53(4): 212-6, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16037865

ABSTRACT

BACKGROUND: The Pericarbon Freedom stentless valve has shown excellent hemodynamic results in the midterm course. However, there is no information as to whether a continuous or interrupted suture technique at the inflow site has an impact on postoperative hemodynamics. METHODS: 139 patients were enrolled in a non-randomized, prospective matched trial. An interrupted suture line technique was used in 68 patients and a continuous suture line technique was used in 71 at the inflow site. Isolated valve replacement was performed in 70.4% of the continuous and 67.6% of the interrupted suture group. Pre- and postoperative hemodynamics and one-year follow-up were obtained by echocardiography and expressed as mean and peak gradients and grade of regurgitation. RESULTS: No significant difference between continuous and interrupted suture techniques were noted with respect to mean (11.8 +/- 6.3 vs. 12.5 +/- 6.2 mm Hg, p = 0.251) and peak gradients (21.0 +/- 9.6 vs. 22.0 +/- 10.9 mm Hg, p = 0.292) as well as to the degree of regurgitation. Bypass and cross-clamping times decreased by 22.4 and 20.6 minutes, respectively, with the use of the continuous suture technique. One year follow-up showed a further, significant decrease of mean and peak gradients. CONCLUSIONS: The Pericarbon Freedom stentless valve appears to offer excellent postoperative performance. The suture line technique at the inflow site does not result in any hemodynamic differences.


Subject(s)
Bioprosthesis , Heart Valve Diseases/mortality , Heart Valve Diseases/surgery , Heart Valve Prosthesis Implantation/methods , Heart Valve Prosthesis , Hemodynamics/physiology , Aged , Aged, 80 and over , Echocardiography, Doppler , Female , Follow-Up Studies , Heart Valve Diseases/diagnostic imaging , Heart Valve Prosthesis Implantation/adverse effects , Humans , Male , Monitoring, Physiologic/methods , Postoperative Complications/mortality , Probability , Prospective Studies , Prosthesis Design , Risk Assessment , Sensitivity and Specificity , Survival Rate , Treatment Outcome
15.
Rofo ; 177(7): 946-54, 2005 Jul.
Article in German | MEDLINE | ID: mdl-15973596

ABSTRACT

The treatment of advanced, drug resistant congestive heart failure gains in importance in the field of cardiac surgery. Cardiac imaging for preoperative assessment and follow-up focuses on the determination of ventricular volumes and function as well as on the detection of postoperative complications. Computed tomography (CT) is highly accurate irrespective of the individual patient's anatomic situation, has a low examiner dependence and short examination time, does not require an arterial vascular access and can be performed in patients with metal implants. CT is the modality of choice in the follow-up of heart transplants to detect extracardiac and cardiac complications including coronary calcifications as an early sign of transplant vasculopathy. In addition, CT visualizes the elements of mechanical assist devices and can identify their possible local cardiac and mediastinal complications. CT can detect fibrolipomatous involution of the mobilized muscle flap in dynamic cardiomyoplasty and can depict fibrous reactions along the epicardial mesh implant in passive cardiac containment. Further indications include assessment of typical local postoperative complications, such as intrathoracic infection and mediastinal bleeding, intracardiac thrombus formation or pericardial effusion. CT is routinely used for evaluating bypass patency but is limited in assessing associated valve defects since it does not visualize flow.


Subject(s)
Cardiovascular Surgical Procedures/methods , Heart Failure/diagnostic imaging , Heart Failure/surgery , Postoperative Care/methods , Preoperative Care/methods , Surgery, Computer-Assisted/methods , Tomography, X-Ray Computed/methods , Clinical Trials as Topic , Humans , Practice Guidelines as Topic , Practice Patterns, Physicians' , Prognosis , Risk Assessment/methods , Risk Factors , Treatment Outcome
16.
Heart Surg Forum ; 8(2): E100-4; discussion E104, 2005.
Article in English | MEDLINE | ID: mdl-15769723

ABSTRACT

OBJECTIVE: This study was performed to evaluate the possibility of creating a glutaraldehyde-free porcine xenograft to improve long-term durability. METHODS: A decellularized porcine pulmonary valve was implanted into the right ventricular outflow tract of 7 juvenile sheep. Valves were explanted after 3 months (n = 4) and 6 months (n = 3). Evaluation was performed by gross examination, radiography, histology (hematoxylin-eosin and Sirius red staining), and immunohistochemistry. Quantitative determination of calcium content was investigated by atomic absorption spectrometry. RESULTS: All animals showed fast recovery without complications. At explantation, all decellularized valves showed smooth and pliable leaflets without evidence of thrombosis. The valve wall was also smooth and pliable without hardness. Light microscopy showed a monolayer of host endothelial cells covering the inner surface of the heart valves and repopulation of host fibroblasts into the deeper layers. Sirius red staining enabled visualization of the production of new collagen. Radiographic results showed an absence of calcification, confirmed by the low calcium levels (1.08 +/- 0.28 microg/g and 0.73 +/- 0.31 microg/g at 3 and 6 months, respectively) revealed by atomic absorption spectrometry. CONCLUSIONS: The results with the juvenile sheep model showed that decellularized heart valves are recellularized in vivo. Host endothelial cells form a monolayer on the inner surface of the valve matrix. Furthermore, host fibroblasts repopulate the valve matrix and produce collagen; thus, a remodeling potential can be expected.


Subject(s)
Bioprosthesis , Heart Valve Prosthesis Implantation , Pulmonary Valve , Tissue Engineering/methods , Animals , Collagen/biosynthesis , Heart Ventricles , Immunohistochemistry/methods , Pulmonary Valve/diagnostic imaging , Pulmonary Valve/metabolism , Pulmonary Valve/pathology , Radiography , Sheep , Spectrophotometry, Atomic , Staining and Labeling , Swine
17.
Acta Anaesthesiol Scand ; 48(6): 697-703, 2004 Jul.
Article in English | MEDLINE | ID: mdl-15196101

ABSTRACT

BACKGROUND: The effect of non-pulsatile, normothermic cardiopulmonary-bypass (CPB) on the splanchnic blood-flow and oxygen-transport, the hepatic function and the gastrointestinal barrier were observed in a prospective observational study in 31 adults undergoing cardiac valve replacement surgery. METHODS: The splanchnic (i.e. hepatic) blood-flow (HBF) was measured by the constant infusion of indocyanine-green (ICG) using a hepatic-venous catheter. Liver function was examined by calculation of lactate uptake, ICG extraction and the monoethylglycinexylidide (MEGX) test. A day before and after surgery the gastrioduodenal and intestinal permeability was measured by determination of sucrose and lactulose/mannitol excretion. RESULTS: Splanchnic blood flow and oxygen delivery did not decrease during and after surgery while splanchnic oxygen consumption (P < 0.0125) and arterial lactate concentrations increased. The splanchnic lactate uptake paralleled the lactate concentration. After but not during CPB an increase of systemic oxygen consumption was observed. The MEGX test values decreased on the first day after surgery. The ICG extraction was attenuated during the operation. The gastroduodenal and the intestinal permeability increased significantly postoperatively (P < 0.002, respectively, P < 0.001). There was no correlation between these findings and the duration of CPB. There was a significant correlation of the intestinal permeability but not of the gastroduodenal permeability between the prior and after surgery values (P < 0.001). CONCLUSION: Increased oxygen consumption during CPB may indicate an inflammatory reaction due to the pump beginning in the splanchnic area or a redistribution of the splanchinc blood flow during the CPB. Normothermic CPB does not lead to a significant or prolonged reduction of liver function. Normothermic CPB causes an increase of gastrointestinal permeability. The intestinal barrier function prior to surgery was accountable for the degree of loss of intestinal barrier function following surgery.


Subject(s)
Cardiopulmonary Bypass/methods , Gastrointestinal Tract/metabolism , Lidocaine/analogs & derivatives , Liver/physiology , Oxygen/blood , Splanchnic Circulation/physiology , Adult , Aged , Aged, 80 and over , Coloring Agents/metabolism , Female , Flurothyl/metabolism , Humans , Lactic Acid/blood , Lactulose/metabolism , Lidocaine/metabolism , Liver/blood supply , Liver/metabolism , Liver Function Tests/methods , Male , Mannitol/metabolism , Middle Aged , Postoperative Complications/metabolism , Prospective Studies , Sucrose/metabolism , Time Factors
18.
Anaesthesist ; 53(2): 163-7, 2004 Feb.
Article in German | MEDLINE | ID: mdl-14991194

ABSTRACT

Levosimendan is a recently developed drug which is not yet approved for clinical routine use in Germany. The clinical use is limited to a few selected cases and it has been used as a salvage therapy in patients with severe heart insufficiency. As a potent inodilator it has been given to patients with severe heart failure, when all other therapeutic options have failed. However, in some European countries levosimendan is used in clinical routine situations and the European Society of Cardiologists has included the drug in their guidelines for treatment of acute heart failure. The following article describes the main pharmacological characteristics of levosimendan and summarises the indications for this new drug for physicians working in the field of anaesthesia or intensive care.


Subject(s)
Cardiotonic Agents/therapeutic use , Heart Failure/drug therapy , Hydrazones/therapeutic use , Pyridazines/therapeutic use , Cardiotonic Agents/administration & dosage , Cardiotonic Agents/adverse effects , Cardiotonic Agents/pharmacokinetics , Heart Failure/physiopathology , Humans , Hydrazones/administration & dosage , Hydrazones/adverse effects , Hydrazones/pharmacokinetics , Pyridazines/administration & dosage , Pyridazines/adverse effects , Pyridazines/pharmacokinetics , Salvage Therapy , Simendan
19.
Tex Heart Inst J ; 30(2): 146-8, 2003.
Article in English | MEDLINE | ID: mdl-12809260

ABSTRACT

We report the case of a 29-year-old male Jehovah's Witness who presented with hemolysis and right heart failure as a consequence of extreme calcification of an aortic valve-containing allograft and Dacron prosthesis that had been placed 22 years earlier to repair tetralogy of Fallot. Reoperation had been denied by several other centers, because of the patient's refusal to undergo blood transfusion. For 2 weeks preoperatively, we raised the patient's hemoglobin level by treating him with recombinant erythropoietin, oral iron, and folic acid. At surgery, under normothermic cardiopulmonary bypass, we replaced the aortic allograft in the right ventricular outflow tract with a cryopreserved pulmonary allograft, also containing a valve. The postoperative course was uneventful, and the patient was released from the hospital on the 13th postoperative day in excellent condition.


Subject(s)
Blood Vessel Prosthesis Implantation , Heart Valve Prosthesis , Jehovah's Witnesses , Postoperative Complications/surgery , Adult , Anemia, Hemolytic/etiology , Aorta/pathology , Calcinosis/surgery , Cardiopulmonary Bypass , Heart Diseases/surgery , Humans , Male , Pulmonary Veins/transplantation , Reoperation , Tetralogy of Fallot/surgery , Time Factors
20.
Acta Radiol ; 44(2): 172-6, 2003 Mar.
Article in English | MEDLINE | ID: mdl-12694104

ABSTRACT

PURPOSE: To evaluate the capability of bright-blood cine MR to directly visualize the leaflets of the valve replacement in pulmonary position following Ross operation. MATERIAL AND METHODS: Long and short axis views of the pulmonary valve were obtained in 10 normal subjects and 14 patients after Ross operation. Valve morphology and function were analyzed and signal-to-noise (SNR) and contrast-to-noise ratios (CNR) were calculated. Flow measurements were performed in the pulmonary trunk to assess pulmonary regurgitation. RESULTS: In all subjects, tricuspid morphology of the pulmonary valve was visualized. SNR of the leaflets in normal subjects (9.8 +/- 3.0) and in patients after Ross operation (7.5 +/- 2.2) differed significantly from blood (12.6 +/- 3.2 and 11.3 +/- 2.5, respectively, p < 0.05). Valvular regurgitation was seen in 5 patients as an insufficient closure of the valve which was confirmed by flow measurements. CONCLUSION: Cine MR enables in-plane visualization of the pulmonary valve and allows for functional and morphological evaluation in patients after pulmonary valve surgery.


Subject(s)
Magnetic Resonance Imaging, Cine , Pulmonary Valve/anatomy & histology , Adult , Female , Humans , Male , Middle Aged , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...